It’s now been 857 days since Starpharma made this statement to the ASX, yet there’s still no licence and/or partner:
’Data from this cohort of prostate cancer patients is being presented in confidential commercial discussions with several potential pharmaceutical companies / partners.’
For context, this announcement was from 2021. One can only assume that these potential partners kicked the tyres, looked under the bonnet and said nope.
Yawn.
It’s now been 857 days since Starpharma made this statement to...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.20M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $29.02K | 281.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 291994 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 72976 | 4 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.5¢ | 10.5¢ | 10.0¢ | 374668 | ||
| Last updated 15.00pm 06/06/2024 ? | |||||
| SPL (ASX) Chart |